Recent trends in drug discovery & drug solubility: A novel hybrid particle-engineering approach to solving the insoluble

Drug Development and Delivery

Volumn 11, Issue 8, 2011, Pages 42-45

  Liversidge, Gary G ^a  

^a Alkermes ^*

Author keywords

[No Author keywords available]

Indexed keywords

AQUEOUS SOLUTION; ARTICLE; CONTROLLED DRUG RELEASE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DEVELOPMENT; DRUG FORMULATION; DRUG INDUSTRY; DRUG SOLUBILITY; DRUG SOLUTION; HYBRID PARTICLE ENGINEERING APPROACH; HYDROPHOBICITY; LIPOPHILICITY; MOLECULAR WEIGHT; OSMOTIC PRESSURE; PHARMACEUTICAL ENGINEERING;

EID: 80054816025     PISSN: 15372898     EISSN: 1944818X     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (5)

1. Di L, et al. Drug-like property concepts in pharmaceutical design. Curr Pharm Des. 2009;15:2184-2194.
2. Stokbroekx S. Formulation effects on drug absorption. bioavailability and bioequivalence: focus on physiological factors and variability. Paper presented at the EUFEPS and COST B25 Conference. October 2007.
3. Benet LZ. Predicting DMPK of NMEs: what do we need in terms of science and tools? Paper presented at the New England Drug Metabolism Discussion Group: Gerald Miwa Retirement Symposium. April 2007.
4. Serajuddin ATM. Lipid-based solid dispersion for oral delivery. Paper presented at the AAPS Workshop on Scientific and Technological Advances in the Use of Lipid-based Drug Delivery Systems for Bioavailability Enhancement and Tissue Targeting. March 2009.
5. Unpublished data, Alkermes.